Lysosomal acidification dysfunction in microglia: an emerging pathogenic mechanism of neuroinflammation and neurodegeneration

JD Quick, C Silva, JH Wong, KL Lim… - Journal of …, 2023 - Springer
Microglia are the resident innate immune cells in the brain with a major role in orchestrating
immune responses. They also provide a frontline of host defense in the central nervous …

Mitochondria‐targeted nanoparticles in treatment of neurodegenerative diseases

Y Zhang, H Yang, D Wei, X Zhang, J Wang, X Wu… - …, 2021 - Wiley Online Library
Neurodegenerative diseases (NDs) are a class of heterogeneous diseases that includes
Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral …

Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease

J Zeng, R Acin-Perez, EA Assali, A Martin… - Nature …, 2023 - nature.com
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world.
High levels of free fatty acids in the liver impair hepatic lysosomal acidification and reduce …

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif… - autophagy, 2021 - Taylor & Francis
In 2008, we published the first set of guidelines for standardizing research in autophagy.
Since then, this topic has received increasing attention, and many scientists have entered …

Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases

CH Lo, J Zeng - Translational Neurodegeneration, 2023 - Springer
Lysosomal acidification dysfunction has been implicated as a key driving factor in the
pathogenesis of neurodegenerative diseases, including Alzheimer's disease and …

Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform

M Pinto, V Silva, S Barreiro, R Silva, F Remião… - Ageing Research …, 2022 - Elsevier
The discovery of effective drugs for the treatment of neurodegenerative disorders (NDs) is a
deadlock. Due to their complex etiology and high heterogeneity, progresses in the …

Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function

M Uzhytchak, B Smolková, M Lunova, A Frtús… - Advanced Drug Delivery …, 2023 - Elsevier
Although several nanomedicines got clinical approval over the past two decades, the clinical
translation rate is relatively small so far. There are many post-surveillance withdrawals of …

Biodegradable polymeric nanoparticles increase risk of cardiovascular diseases by inducing endothelium dysfunction and inflammation

W Shi, ARM Fuad, Y Li, Y Wang, J Huang, R Du… - Journal of …, 2023 - Springer
Biodegradable polymers are expected to be an alternative to plastics. Because of its high
biocompatibility, poly (lactic-co-glycolic acid)(PLGA) is widely used in medicine. It has been …

Engineered biomimetic micro/nano-materials for tissue regeneration

F Han, Q Meng, E Xie, K Li, J Hu, Q Chen… - … in Bioengineering and …, 2023 - frontiersin.org
The incidence of tissue and organ damage caused by various diseases is increasing
worldwide. Tissue engineering is a promising strategy of tackling this problem because of its …

PLGA-based nanoparticles for neuroprotective drug delivery in neurodegenerative diseases

A Cunha, A Gaubert, L Latxague, B Dehay - Pharmaceutics, 2021 - mdpi.com
Treatment of neurodegenerative diseases has become one of the most challenging topics of
the last decades due to their prevalence and increasing societal cost. The crucial point of the …